ClinicalTrialExchange
  • Home
  • For Patients
  • For Professionals
  • About
  • Contact

Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Craniosynostoses

  • Effects of Methylphenidate on Brain and Cognition in 22q11 Deletion Syndrome
  • Neuroprotective Effects of Risperdal on Brain and Cognition in 22q11 Deletion Syndrome
  • Comparison of the Rate of Preoperative Haemoglobin After Administration of Epoetin Alpha Associated With an Oral Medical Supplementation Versus Intravenous Before Surgery of Craniosynostosis at the Child
  • Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric Conditions
  • Efficacy of Amicar for Children Having Craniofacial Surgery
  • The Efficacy and Population Pharmacokinetics of Tranexamic Acid for Craniosynostosis Surgery
  • Effect of Tranexamic Acid Based on Pharmacokinetics in Pediatric Patients Undergoing Craniosynostosis Surgery: Randomized Controlled Trial
  • Thymus Transplantation Safety-Efficacy
  • Blood Loss and Transfusion Requirement in Infants Treated With Tranexamic Acid
  • Amicar Pharmacokinetics of Children Having Craniofacial Surgery
  • The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome
  • Tranexamic Acid for Craniofacial Surgery
  • Phase I/II Thymus Transplantation With Immunosuppression #950
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies

Clinical Trials data from clinicaltrials.gov

Powered by DrugPatentWatch.

  • About
  • Contact
  • Follow ClinicalTrialsExchange:

      ClinicalTrialsExchange Linkedin Group